This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

California SB 243: Setting New Standards For Regulating And Ensuring Integrity Of AI Companion Chatbots

The rapid advancement of artificial intelligence ("AI") has spurred remarkable innovation for the healthcare industry, while also resulting in swiftly emerging regulatory frameworks.

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Eleventh Circuit Hears Oral Arguments In High-Profile Challenge To Constitutionality Of The False Claim Act's Qui Tam Provision

Today, the Eleventh Circuit heard oral argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, a case addressing the constitutionality of qui tam relators that has drawn national attention.

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

European Biosimilar Updates – Six Denosumab Launches And Positive Opinion For Samsung Bioepis's BYOOVIZ

Just in December, six companies have announced the launch of their denosumab biosimilars in Europe: Sandoz, Samsung Bioepis, Fresenius Kabi, Zentiva, Biocon Biologics, and Accord.

United States Healthcare

GP

Goodwin Procter LLP

CMS Finalizes Medicare Payment Policies For Hospital Outpatient And Ambulatory Surgery Center Services

The Centers for Medicare & Medicaid Services ("CMS") final rule for Medicare payment for services provided in hospital outpatient departments (paid under the Outpatient Prospective Payment System or "OPPS")...

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Claiming Your Drug Product Is Unique: Does That Mean It's Superior?

United States Healthcare

LL

Loeb & Loeb LLP

FDA Proposes First New Sunscreen Ingredient In Decades

United States Healthcare

HK

Holland & Knight

New Bipartisan Bill Seeks To Expand Medicare ACO Assignment Rules

United States Healthcare

NM

Nelson Mullins Riley & Scarborough LLP

PBMs As De Facto Regulators: A 2025 Recap Of PBM Audits And Their Growing Impact On Board Of Pharmacy Enforcement

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

USDA Announces Federal Actions, $700 Million For Regenerative Agriculture Practices

United States Healthcare

HK

Holland & Knight

DMEPOS Suppliers Subject To 36-Month Rule For Change In Majority Ownership And Minimum Annual Surveys

United States Healthcare

BB

Bass, Berry & Sims

New Guidance For New York State Health Facility Closures

United States Healthcare

GT

Greenberg Traurig, LLP

CMS Obtains Meaningful Discounts For IPAY 2027 Selected Drugs

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

FDA Approves BMS's BREYANZI As First MZL CAR T Therapy

United States Healthcare

GP

Goodwin Procter LLP

Training Localization Mistakes Are Costing You More Than You Think

United States Healthcare

Moringside

See more

Webinars

See More

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Recorded on 21 Jan 2025 | 3:00 PM

2025 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CCCA | Mondaq

TC

CBA In-House Lawyers

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

Eleventh Circuit Hears Oral Arguments In High-Profile Challenge To Constitutionality Of The False Claim Act's Qui Tam Provision

Today, the Eleventh Circuit heard oral argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, a case addressing the constitutionality of qui tam relators that has drawn national attention.

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

The Federal Circuit Raises The Section 112 Stakes For Chemical Structures In Seagen v. Daiichi

On December 2, 2025, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision in Seagen Inc. v. Daiichi Sankyo Company Ltd., which further clarifies the amount of disclosure a US...

United States IP

GP

Goodwin Procter LLP

Claiming Your Drug Product Is Unique: Does That Mean It's Superior?

Brands and marketers seek to highlight what makes their products singular and unique. But it can be very challenging to do so in a manner...

United States Healthcare

LL

Loeb & Loeb LLP

Food Venture Financing News – Weekly Issue No. 264

United States Commercial

DW

Davis Wright Tremaine

FDA Proposes First New Sunscreen Ingredient In Decades

United States Healthcare

HK

Holland & Knight

USDA Announces Federal Actions, $700 Million For Regenerative Agriculture Practices

United States Healthcare

HK

Holland & Knight

New Guidance For New York State Health Facility Closures

United States Healthcare

GT

Greenberg Traurig, LLP

CMS Obtains Meaningful Discounts For IPAY 2027 Selected Drugs

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

FDA Approves BMS's BREYANZI As First MZL CAR T Therapy

United States Healthcare

GP

Goodwin Procter LLP

See more

Life Sciences, Biotechnology & Nanotechnology

European Biosimilar Updates – Six Denosumab Launches And Positive Opinion For Samsung Bioepis's BYOOVIZ

Just in December, six companies have announced the launch of their denosumab biosimilars in Europe: Sandoz, Samsung Bioepis, Fresenius Kabi, Zentiva, Biocon Biologics, and Accord.

United States Healthcare

GP

Goodwin Procter LLP

PBMs As De Facto Regulators: A 2025 Recap Of PBM Audits And Their Growing Impact On Board Of Pharmacy Enforcement

Pharmacy Benefit Managers have long operated as de facto regulators of pharmacies, but in 2025 their regulatory influence became more prevalent, more coordinated and more transparent.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Artificial Intelligence In Clinical Decision-Making: Regulatory Roadmap And Reimbursement Strategies

Artificial intelligence is rapidly transforming clinical medicine, with AI-powered tools increasingly being used for diagnostic imaging interpretation, clinical decision support, predictive analytics and treatment planning.

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

FDA's Support For Onshoring Drug Manufacturing And Increasing Oversight Of Foreign Facilities

United States Healthcare

JD

Jones Day

Return Of The BIOSECURE Act: What Life Sciences Companies Need To Know

United States Healthcare

PL

Polsinelli LLP

Commissioner's National Priority Voucher Program And Coverage Considerations

United States Healthcare

JD

Jones Day

CMS Indefinitely Suspends Off-Cycle Revalidation Deadline For Skilled Nursing Facilities

United States Healthcare

HK

Holland & Knight

When Is An Approval Not An Approval? Before 1962.

United States Healthcare

HP

Hyman, Phelps, & McNamara

UPC: CE Marking For A Medical Device As A Trigger For "Imminent Infringement", Refining The Standard On Imminence, Urgency, And Territorial Scope

Worldwide Healthcare

AO

A&O Shearman

See more

Healthcare

California SB 243: Setting New Standards For Regulating And Ensuring Integrity Of AI Companion Chatbots

The rapid advancement of artificial intelligence ("AI") has spurred remarkable innovation for the healthcare industry, while also resulting in swiftly emerging regulatory frameworks.

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

New DOJ Health And Safety Unit Formed To Protect Consumers

On December 2, 2025, the Department of Justice (DOJ) announced the launch of a new unit within the Criminal Division's Fraud Section, called the Health & Safety Unit (HSU).

United States Criminal

DM

Duane Morris LLP

Eleventh Circuit Hears Oral Arguments In High-Profile Challenge To Constitutionality Of The False Claim Act's Qui Tam Provision

Today, the Eleventh Circuit heard oral argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, a case addressing the constitutionality of qui tam relators that has drawn national attention.

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

CMS Finalizes Medicare Payment Policies For Hospital Outpatient And Ambulatory Surgery Center Services

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

FDA Proposes First New Sunscreen Ingredient In Decades

United States Healthcare

HK

Holland & Knight

New Bipartisan Bill Seeks To Expand Medicare ACO Assignment Rules

United States Healthcare

NM

Nelson Mullins Riley & Scarborough LLP

PBMs As De Facto Regulators: A 2025 Recap Of PBM Audits And Their Growing Impact On Board Of Pharmacy Enforcement

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

DMEPOS Suppliers Subject To 36-Month Rule For Change In Majority Ownership And Minimum Annual Surveys

United States Healthcare

BB

Bass, Berry & Sims

New Guidance For New York State Health Facility Closures

United States Healthcare

GT

Greenberg Traurig, LLP

See more

Latest Videos

See more

Strategic Synergy At Atlantic Health: Saad Ehtisham On How Leadership Alignment Fuels Transformation (Video)

AM

Alvarez & Marsal

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

WHLC Summit - Day One Recording (Video)

SM

Sheppard Mullin Richter & Hampton

Navigating Women's Health With Rachel Welch (Video)

OK

Offit Kurman

Upcoming Events

Join Arnold & Porter’s Global Life Sciences Industry Group During The J.P. Morgan Healthcare Conference

United States Healthcare

AP

Arnold & Porter

The Mass League Health Center Compliance Academy: Pharmacy/340B

United States Healthcare

FH

Foley Hoag LLP

BBS Connect At 44th Annual J.P. Morgan Healthcare Conference

United States Healthcare

BB

Bass, Berry & Sims

All In The Family - After The Wedding: AMC And Community Hospital Affiliations In Practice - American Health Law Association Academic Medical Centers Conference

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

BIO Partnering™ @JPM Week 2026

United States Healthcare

FH

Foley Hoag LLP

Healthcare Regulatory & Compliance Summit

United States Healthcare

BB

Bass, Berry & Sims

Pharmaceutical EHS Counsel Roundtable

United States Healthcare

BD

Beveridge & Diamond

2026 JP Morgan Healthcare Conference Reception

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More